Virbac: driven by very solid performance in all areas and a very dynamic market, we are raising our outlook for 2021
2021 OutlookThe animal health sector has shown excellent dynamism in the first months of 2021. A number of indicators, such…
Pharmaceuticals, Biotechnology and Life Sciences
2021 OutlookThe animal health sector has shown excellent dynamism in the first months of 2021. A number of indicators, such…
Saint Herblain (France), July 5, 2021 –Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company focused on the…
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. PUBLICATION RELATING TO A TRANSPARENCY NOTIFICATION(ARTICLE 14, 1ST PARAGRAPH, OF THE LAW OF 2 MAY…
— ORR of 72% Observed in Patients with >2L HER2 Positive Gastric or Gastroesophageal Junction Cancer — Estimated OS at 12…
CAMBRIDGE, Mass., July 01, 2021 (GLOBE NEWSWIRE) — Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of…
SHANGHAI, China, July 02, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated…
HANGZHOU, China, July 02, 2021 (GLOBE NEWSWIRE) — Hangzhou Chance Pharmaceuticals (“Chance”), a clinical-stage biotechnology company focusing on discovering, developing,…
DUBLIN, Ireland and CHICAGO, July 01, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical…
Management works to advance its BLA filing seeking FDA approval for leronlimab as a combination therapy for HIV patients while…
SAN DIEGO, July 01, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW) today…